autologous CD4+/CD8+ T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19

autologous CD4+/CD8+ T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19
Trade Name
Orphan Indication Acute lymphoblastic leukemia
USA Market Approval USA
USA Designation Date 2014-11-06 00:00:00
Sponsor Juno Therapeutics, Inc.;307 Westlake Avenue, North, Suite 300;Seattle, Washington, 98109
Related Access Program
Novartis Pharmaceuticals – Acute Lymphoblastic Leukemia University of California, San Francisco – Acute Lymphoblastic Leukemia ERYtech Pharma – Acute Lymphoblastic Leukemia University of California, San Francisco – Acute lymphoblastic leukemia ERYtech Pharma – Acute lymphoblastic leukemia Amgen – Acute lymphoblastic leukemia